Literature DB >> 6309379

Biochemical and quantitative histochemical study of reduced pyridine nucleotide dehydrogenation by human colonic carcinomas.

N A Schor, C J Cornelisse.   

Abstract

This study shows a marked increase in the activity of the soluble enzyme DT-diaphorase and of the histochemical activity of the reduced nicotinamide adenine dinucleotide and reduced nicotinamide adenine dinucleotide phosphate nitroblue tetrazolium menadione-mediated reductases in human colonic carcinomas when compared with the enzymatic activities of portions of the colon uninvolved by the carcinomatous process. The activity of the reductases in histological sections was quantitated with a microphotometer. It is believed that the increase in histochemical nitroblue-tetrazolium reductase activity in the histochemical reactions in colonic carcinomas is a real reflection of the activity of the DT-diaphorase, because the increase in the dehydrogenation of reduced nicotinamide adenine dinucleotide equals the dehydrogenation of reduced nicotinamide adenine dinucleotide phosphate when measured biochemically in the soluble fraction, or histochemically, by microspectophotometry in tissue sections; meanwhile, the biochemical dehydrogenation of NAD(P)H by the particulate fractions shows that the enzymatic activities are not altered by the neoplastic process. The biological significance of these changes is discussed in the text.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6309379

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  Expression of human NAD(P)H: quinone oxidoreductase (DT-diaphorase) in Chinese hamster ovary cells: effect on the toxicity of antitumor quinones.

Authors:  D L Gustafson; H D Beall; E M Bolton; D Ross; C A Waldren
Journal:  Mol Pharmacol       Date:  1996-10       Impact factor: 4.436

Review 2.  NAD(P)H:quinone oxidoreductase1 (DT-diaphorase) expression in normal and tumor tissues.

Authors:  M Belinsky; A K Jaiswal
Journal:  Cancer Metastasis Rev       Date:  1993-06       Impact factor: 9.264

Review 3.  The bioactivation of CB 1954 and its use as a prodrug in antibody-directed enzyme prodrug therapy (ADEPT).

Authors:  R J Knox; F Friedlos; M P Boland
Journal:  Cancer Metastasis Rev       Date:  1993-06       Impact factor: 9.264

4.  DT-diaphorase and cytochrome B5 reductase in human lung and breast tumours.

Authors:  A Marín; A López de Cerain; E Hamilton; A D Lewis; J M Martinez-Peñuela; M A Idoate; J Bello
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  NAD(P)H nitroblue tetrazolium reductase levels in apparently normoxic tissues: a histochemical study correlating enzyme activity with binding of radiolabelled misonidazole.

Authors:  L M Cobb; T Hacker; J Nolan
Journal:  Br J Cancer       Date:  1990-04       Impact factor: 7.640

6.  DT-diaphorase activity in normal and neoplastic human tissues; an indicator for sensitivity to bioreductive agents?

Authors:  E Smitskamp-Wilms; G Giaccone; H M Pinedo; B F van der Laan; G J Peters
Journal:  Br J Cancer       Date:  1995-10       Impact factor: 7.640

7.  Immunological quantitation of DT-diaphorase in carcinoma cell lines and clinical colon cancers: advanced tumors express greater levels of DT-diaphorase.

Authors:  K Mikami; M Naito; T Ishiguro; H Yano; A Tomida; T Yamada; N Tanaka; T Shirakusa; T Tsuruo
Journal:  Jpn J Cancer Res       Date:  1998-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.